First-lineLustral

Sertraline

SSRI

First-line antidepressant in pregnancy and breastfeeding.

Oral

First-line for

  • Depression in pregnancy
  • Postnatal depression
  • Anxiety disorders, OCD, PTSD in perinatal period

Mechanism

Selective serotonin reuptake inhibition at SERT → ↑ synaptic 5-HT.

"Sertraline stays low in milk"

  • Relative infant dose <2% — first-choice SSRI in lactation
  • Onset 4–6 weeks — warn about initial anxiety spike
  • Wean to avoid discontinuation syndrome

Dosing

Start
50 mg OD (25 mg if anxious presentation)
Titrate
Increase by 50 mg every 2–4 weeks; max 200 mg/day

Contraindications

  • AbsoluteConcurrent MAOI (serotonin syndrome)
  • CautionBleeding disorders, epilepsy

Side effects

  • Nausea, diarrhoea (first weeks)
  • Sexual dysfunction
  • Insomnia or somnolence
  • Hyponatraemia (SIADH, elderly)

Fetal & maternal notes

  • No teratogenic signal
  • Late 3rd trimester: neonatal adaptation syndrome (jittery, feeding difficulty) — do NOT stop, self-limits in <2 weeks
  • PPHN absolute risk <1%

Key interactions

  • Tramadol / pethidine / linezolid

    Avoid

    Serotonin syndrome

  • NSAIDs / aspirin

    Caution

    ↑ GI bleed risk

  • Warfarin

    Caution

    ↑ INR, bleeding

Clinical pearls

  • 💡 Do not stop untreated depression in pregnancy — untreated illness carries greater fetal risk
  • 💡 Talking therapy always offered alongside medication

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.